… However, the results obtained with PD 128907 are incompatible with this simple interpretation
because this putative D 3 receptor-selective agonist inhibited DA release by the same …

… In 1971, Farnebo and Hamberger reported that the dopamine receptor agonist … with 3H-dopamine.
They proposed that the release of doparnine is subject to a local, doparnine receptor…

… , only apomorphine and pergolide have activity on both D1 and D2 receptors, and the
remaining dopamine receptor agonists generally interact with D2 receptors. It has been …

… Dopamine receptor agonists are indicated for … dopamine agonists, such as bromocriptine
or pergolide, were initially developed and marketed, and then non-ergolinic dopamine agonists…

… dopamine D 1 and D 2 receptors agonists and antagonists on extracellular dopamine release
… Cortical dopamine release was tetrodotoxin- and calcium-dependent and was stimulated …

… Modulation of in vivo dopamine release by D2 but riot D, receptor agonists and antagonists.
… on dopamine release of D1-selective drugs compared to the effects of D2 compounds. …

… dopamine agonist which causes dopaminergic renal vasodilation, was tested for central
dopaminergic … In contrast to other dopamine agonists, SK & F 38393 did not cause stereotypy, …

… conclusion that dynorphin inhibits dopamine release by activating k-opioid receptors, … for
antagonism than pu-receptors". Thus, the inhibition of "Hdopamine release caused by 0.03 pM …

… agonists and monitor changes in DA release in vivo. we found that striatal perfusion of SHT,
agonists increased extraneuronal levels of dopamine … by the direct agonists is not secondary …

… The following agonists and antagonists were purchased from Research Biochemicals Inc.(Natick,
MA): 8-OH-DPAT; DOI; 5-MT; ritanserin 6-[2-[4 [bis (4-fluorophenyl) methylene]-1-…